Compare Oscar Health Inc (OSCR) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Wendys Co — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Wendys Co trades at $6.23 (market cap $1.19B). The key difference: Oscar Health Inc is far larger — about 8.6× Wendys Co's market cap, and Wendys Co pays a 4.49% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Wendys Co for 77 Days on average.
| OSCR | WEN | |
|---|---|---|
Market Cap | $10.22B | $1.19B |
Volume | 4,123,394 | 5,622,905 |
Sector | Health | Consumer Cyclical |
52-Week High | $33.81 | $9.33 |
52-Week Low | $10.85 | $6.10 |
Typical Hold Time | 15 Days | 77 Days |
Enterprise Value | $6.57B | $4.92B |
Dividend Yield | — | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
WEN trades at $6.22, up 1.8% today, but remains near multi-year lows amid bearish technical signals and fundamental pressures. The stock shows low valuation multiples (P/E 9.45, P/S 0.54) and a high ROE of 108.04%, yet faces declining net income margins (7.58% in 2025) and negative sentiment from recent franchisee bankruptcies. Earnings have consistently beaten estimates, but same-store sales declines and high debt levels ($2.66B long-term) weigh on investor confidence.
The outlook is cautious; while valuation appears cheap and dividend yield offers income, competitive pressures, shrinking sales, and leveraged balance sheet pose significant risks. Analyst consensus is 'Hold' with a $7.58 price target, suggesting limited upside without operational turnaround under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
